Beta Bionics (BBNX) Research & Development (2024 - 2026)

Beta Bionics has disclosed Research & Development across 3 years of filings, most recently posting $24.6 million for Q2 2026.

• In Q2 2026, Research & Development rose 57.72% year-over-year to $24.6 million; the TTM figure through Jun 2026 stood at $77.8 million (up 57.16% YoY), while the FY2025 annual figure was $61.4 million, up 65.57% from the prior year.
• Research & Development came in at $24.6 million for Q2 2026 at Beta Bionics, up from $20.7 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $24.6 million in Q2 2026 to a low of $7.7 million in Q1 2024.
• Average Research & Development over 3 years is $14.4 million, with a median of $14.5 million recorded in 2025.
• The largest YoY upside for Research & Development was 74.89% in 2025 against a maximum downside of 51.18% in 2025.
• Over 3 years, Research & Development stood at $10.8 million in 2024, then jumped by 51.18% to $16.3 million in 2025, then soared by 50.85% to $24.6 million in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $24.6 million in Q2 2026, $20.7 million in Q1 2026, and $16.3 million in Q4 2025.